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Antibiotic export: transporters involved in the final step of
natural product production
Emmanuele Severi* and Gavin H. Thomas
Abstract
In the fight against antimicrobial resistance (AMR), antibiotic biosynthetic gene clusters are constantly being discovered.
These clusters often include genes for membrane transporters that are involved in the export of the produced natural
product during biosynthesis and/or subsequent resistance through active efflux. Despite transporter genes being integral
parts of these clusters, study of the function of antibiotic export in natural producers such as Streptomyces spp. remains
underexplored, in many cases lagging far behind our understanding of the biosynthetic enzymes. More efficient release of
antibiotics by producing cells has potential benefits to industrial biotechnology and understanding the relationships between
exporters in natural producers and resistance-associated efflux pumps in pathogens can inform our efforts to understand
how AMR spreads. Herein we compile and critically assess the literature on the identification and characterization of
antibiotic exporters and their contribution to production in natural antibiotic producers. We evaluate examples of how this
knowledge could be used in biotechnology to increase yields of the final product or modulate its chemical nature. Finally, we
consider the evidence that natural exporters form a reservoir of protein functions that could be hijacked by pathogens as
efflux pumps and emphasize the need for much greater understanding of these exporters to fully exploit their potential for
applications around human health.
INTRODUCTION
Antimicrobial resistance (AMR) is one of the most urgent
global challenges to human health [1, 2]. The scarcity of
effective antimicrobials against multidrug-resistant (MDR)
pathogens has led the mainstream media to warn of an
‘antibiotic apocalypse’ [3], and has compelled the scientific
community to direct considerable effort at the discovery of
novel molecules able to combat such organisms [4–7].
As new antimicrobials are identified, much academic
research strives to detail the biosynthetic steps generating
these novel chemistries, in the hope that such understand-
ing can be harnessed for new generations of effective and
commercially viable therapeutics [8]. As a result, novel bio-
synthetic gene clusters (BGCs) for antibiotics are being
reported in ever-growing numbers from genome and envi-
ronmental DNA sequencing projects. The biochemical char-
acterization of these BGCs is often accompanied by efforts
to optimize the performance of the BGCs in native or heter-
ologous hosts to increase yields, with studies that unveil the
regulation of these BGCs and/or use innovative synthetic
biology approaches in order to unlock the full potential of
each pathway [9–14].
BGCs often contain genes for exporters [15, 16], integral
membrane proteins responsible for the secretion of an enor-
mous variety of molecules including antibiotics (Fig. 1). The
vast majority of BGC-linked antibiotic exporters belongs to
various subgroups of the ATP-binding cassette (ABC)
superfamily and major facilitator superfamily (MFS) of
transporters (Fig. 1, Table 1), which while differing by struc-
ture, transport mechanism, and mode of energization
(Fig. 1) [17, 18], collectively also account for much of
efflux-related MDR in nature [19]. While it is commonly
assumed that BGC-linked exporters function in the secre-
tion of the antibiotic made by the BGC, the exact nature
and importance of their physiological role have been rela-
tively poorly studied and very rarely exploited in biotechno-
logical approaches to improve antibiotic production. Most
studies that discover and manipulate BGCs involved strate-
gies that only focus on the biosynthetic genes [20] and do
not consider manipulating export as an option.
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Fig. 1. Diversity of BGC-linked exporters from bacterial antibiotic producers. (a) Examples of antibiotic exporters of the ABC superfamily. Different colours identify distinct transport-
ers and, in order to convey the existing genetic diversity, they also differentiate subunits encoded by separate genes within individual transporters. All these transporters are dis-
cussed in the text except for the pyoluteorin exporter PltHIJKN (Table 1), which is here included as an example of envelope-spanning RND exporters from Gram-negative producers.
Please note the distinct roles of NisT and NisFEG from L. lactis in, respectively, secretion of inactive pre-nisin and self-immunity to mature, active nisin. The 3D structures of PCAT1,
of the same family as NukT, and McjD were adapted from PDB entries 4RY2 and 4PL0, respectively, using CCP4MG [87]. (b) Examples of antibiotic exporters of the MFS superfamily.
Different shapes identify distinct entries in TCDB (Table 1). ‘X+’ indicates that the identity of the ion gradient energizing transport has not been established or cannot be predicted for
that particular transporter. ActA and ActB are shown paired, because they have been studied together, but their individual roles have not been established. Cmx and Ptr are included
as respective examples of an AMR-linked exporter that originated from a BGC, and of an MDR efflux pump that is closely related to a BGC-linked exporter (here, VarS). All these
examples are discussed in the text. CM/IM: cytoplasmic/inner membrane; PG: peptidoglycan; OM: outer membrane; TMD: transmembrane domain; NBD: nucleotide-binding domain;
PEP: peptidase domain; RiPPs: ribosomally synthesised and post-translationally modified peptides.
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Transporters – exporters and importers alike – are not only
key players in innumerable biological processes, but they
are emerging objects of interest in industrial biotechnology
where their function can be exploited to optimize flux bal-
ances and enhance productivity in industrial strains [21].
Exporters are particularly attractive as means of detoxifica-
tion, by which toxic end products can be relocated from
inside the cell to the external milieu to give more durable
and sustained outputs [22]. Importantly, even in the
absence of toxicity, the ability to secrete the end product
adds much value to the production process by reducing the
costs and labour associated with product extraction and
purification [21]. Therefore, we argue it is time for a new
appreciation of transporter research in the context of antibi-
otic production.
Crucially, exporters also stand out for the direct role they
play in AMR, if one only considers the important contribu-
tion of the so-called ‘efflux pumps’ during resistance in
pathogens [23]. While long hypothesized, it has now been
established that AMR-linked exporters can be phylogeneti-
cally related to exporters of antibiotic biosynthetic path-
ways, from which they have arisen through horizontal gene
transfer (HGT) events [24]. This discovery expands to
exporters the arsenal of AMR factors that natural antibiotic
producers may disseminate in the environment and ulti-
mately source to human pathogens [24, 25]. When the
above observations are taken together, it becomes para-
mount that we understand how the function of different
exporters is integrated within the wider process of antibiotic
production, so that we can exploit its potential in antibiotic
manufacturing and evaluate its risk for AMR dissemination.
Previous reviews by others have captured important aspects
of antibiotic export, with some works focussing exclusively
on bacterial ABC exporters [26, 27], other works touching
on export while discussing self-immunity in producers [28]
or the overall biology of specific antibiotic classes [29–31],
and finally works dealing more generally with secondary
metabolite exporters of different phylogenetic and organis-
mal origins [15]. Drawing from all these examples, here we
put together an updated compendium encompassing all
families of bacterial exporters that nonetheless are specifi-
cally linked to antibiotic production (Fig. 1, Table 1). Our
aim is to lay the foundations of a framework with which to
connect the properties of antibiotic exporters in native pro-
ducers to both their suitability for biotechnological applica-
tions and their likelihood to evolve in to AMR factors.
Through a selection of significant examples, we first illus-
trate the many different ways BGC-linked exporters may be
implicated with antibiotic production, and we finally discuss
what impact this information might have on the needs of
the biotech industry on one side and the concerns of AMR
research on the other.
Reassessment of transporters linked to antibiotic
export
The literature contains a large and disparate body of evi-
dence that has linked genes encoding potential exporters
to antibiotic production. For consideration in this review
we used strict criteria for inclusion, which were as follows:
(i) that the exporter genes be genetically linked to the
BGC; (ii) that they code for at least one membrane protein
component of an acknowledged exporter family; and (iii)
that there be experimental evidence to implicate the action
of these exporters with antibiotic production (Table 1).
This was an important quality control due to many indi-
rect assertions of roles in export that confuse the literature.
For example, an important ‘false positive’ in this field are
the ABCF proteins, which are now known to use their
ATPase activity to function directly in ribosome protection
[32] and not to form part of novel ABC efflux systems as
had been hypothesized for a long time (for an excellent
recent discussion of ABCF proteins see [33]). The audit
also revealed significant differences in the experimental
evidence used to study antibiotic export. Exporters have
collectively been implicated in all aspects of antibiotic pro-
duction, including, e.g. biosynthesis proper (i.e. the physi-
cal maturation of the antibiotic molecule), BGC
transcriptional regulation, and self-immunity. This is com-
pounded by the plethora of experimental approaches and
techniques, in vivo and in vitro, genetic and biochemical,
that researchers have used over the years to inform differ-
ent questions as to the physiological roles, substrate speci-
ficity and mechanisms of export.
The compendium we produced is contained in Table 1,
where it is clear that exporters belong to many different
families and subfamilies of transporters, which we for-
malized by using TCDB identifiers [34] wherever possi-
ble, and come from organisms as diverse as
Actinobacteria, Firmicutes and Proteobacteria. The fol-
lowing sections of the review examine examples of differ-
ent evidence/functional types from this table to illustrate
the variety of evidence and proposed functional roles of
these exporters. This starts with exporters directly cou-
pled to antibiotic biosynthesis/export and those with
known roles in self-immunity.
Export directly linked to antibiotic maturation
Among the best-studied BGC-encoded transporters with
strong evidence of a direct function in product export are
examples where the exporter itself has a bifunctional role in
the antibiotic’s final maturation as well as export (Table 1,
Fig. 1a). These examples are exporters of some RiPP (ribo-
somally synthesised and post-translationally modified pep-
tide) antibiotics, namely class I and II lantibiotics, and a few
of these have been described to molecular detail using in
vitro assays with purified components, and crystal structures
in some cases (Fig. 1a; see below).
For both classes of lantibiotics, the function of a dedi-
cated ABC transporter, generally termed ‘LanT’ [31], is
required for the actual formation of the final product.
Structurally, ABC transporters are multisubunit com-
plexes that use the direct binding and hydrolysis of ATP
to drive the transport cycle, and usually consist of two
integral membrane protein subunits and two ATPases.
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Table 1. Exporters of antibiotic-producing bacteria
Exporter SFa TCDB BGCb Class Producer GO Evidence
Codesc
NisT ABC 3.A.1.111.3 Nisin RiPP (Class I
lantibiotic)
Lactococcus lactis IDA[35], IMP
35, 36]
NisFEG ABC 3.A.1.124.1 Nisin RiPP (Class I
lantibiotic)
Lactococcus lactis IDA[88]
NukT ABC 3.A.1.111.7 Nukacin IKS-1 RiPP (Class II
lantibiotic)
Staphylococcus warneri ISK-1d IDA[37–39], IMP
[38]
PCAT1 ABC 3.A.1.112.9 Cthe_0535e RiPP Clostridium thermocellum IDA[40]
McjD ABC 3.A.1.118.1 MccJ25 RiPP (lassopeptide) Escherichia colid IDA[44, 45], IMP
[43, 46]
McbEF ABC 3.A.1.116.1 MccB17 RiPP (microcin) Escherichia colid/ Pseudomonas
syringae
IMP[89, 90]
KlpE ABC Klebsazolicin RiPP Klebsiella pneumoniae subps.
ozaenae
IDA[91]f
CinTH ABC Cinnamycin RiPP Streptomyces cinnamoneus
DSM 40646
IMP[92]
MibEF ABC Microbisporicin RiPP Microbispora corallina IMP[70]
PspEF ABC Planosporicin RiPP Planomonospora alba IDA[69]f, IMP[67]
PspTU ABC Planosporicin RiPP Planomonospora alba IMP[69]PspYZ
ABC 3.A.1.148.2 Planosporicin RiPP Planomonospora alba IMP[69]
Tba ABC Balhimycin Glycopeptide Amycolatopsis bahlimycina IDA[93]
MoeX5-P5 ABC Moenomycin Phosphoglycolipid Streptomyces ghanaensis
ATCC14672
IDA[79]
CmrAB ABC 3.A.1.105.3 Chromomycin Aureolic acid Streptomyces griseus subsp.
griseus
IDA[55]f
MtrAB ABC Mithramycin Aureolic acid Streptomyces argillaceus IDAf, IMP[56]
AvtAB ABC Avermectin Macrocyclic lactone Streptomyces avermitilis IDA[74]
PpzR1, PpZR2g ABC Endophenazines Pyrazine Streptomyces anulatus 9663 IGI[94]
DrrAB ABC 3.A.1.105.1 Doxorubicin Anthracycline Streptomyces peucetius IDA[51, 52]f, IMP
[53]
NysGHh ABC Nystatin Polyene macrolide Streptomyces noursei ATCC
11455
IMP[42]
OleC4-C5 ABC 3.A.1.105.2 Olenadomycin Macrolide Streptomyces antibioticus IDA[95, 96]f
PltHIJKN ABC 3.A.1.105.4 Pyoluteorin NRPS-PKS hybridi Pseudomonas spp.j IDA(97)f, IMP
(97, 98)
NovA ABC Novobiocin Aminocoumarin Streptomyces niveus IDA[99]f, IGI[100]
SimX MFS Simocyclinone Aminocoumarin Streptomyces antibioticus Tü
6040
IDA[72]f
CouR5 MFS Coumermycin A1 Aminocoumarin Streptomyces rishiriensis DSM
40489
IDA[99]f
MccC MFS 2.A.1.61.1 MccC51 RiPP (microcin) Escherichia colid IMP[101]
BotT MFS Bottromycin RiPP Streptomyces sp. BC16019 IMP[73]
TblR MFS Tabtoxin b-lactam Pseudomonas syringae BR2 IGI[102]
LanJ MFS 2.A.1.3.32 Landomycin A Angucycline Streptomyces cyanogenus S136 IDA, IMP[103]
LndJ MFS 2.A.1.3.32k Landomycin E Angucycline Streptomyces globisporus IDA, IMP[75]
AbmD MFS Abyssomycin Tetronate Streptomyces koyangensis
SCSIO 5802
IMP[104]
VarS MFS 2.A.1.3.5l Virginiamycin S Streptogramin B Streptomyces virginiae IDA[62, 105]f
PhlE MFS 2.A.1.45.1 2,4-
diacetylphloroglucinol
Phenolic
compound
Pseudomonas fluorescenes
F113
IMP[106]
Hyg19 MFS Hygromycin A Aminoglycoside Streptomyces hygriscopicus
NRRL 2388
IMP[107]
TcmA MFS 2.A.1.3.12 Tetracenomycin Anthracycline Streptomyces glaucescens IDA[108]f
Mmr MFS Methylenomycin Cyclopentenoid Streptomyces coelicolor A3(2)d IDA[109, 110]f
FacT MFS Factumycin Elfamycin Streptomyces sp. WAC5292 IDA[111]f
OtrB MFS 2.A.1.3.29 Oxytetracycline Naphthacene Streptomyces rimosus IDA[57–59]f,
IMP[60, 61]
LmrA MFS 2.A.1.3.9 Lincomycin Lincosamide Streptomyces lincolnensis IDA[112, 113]f
Mct MFS Mitomycin C Aziridine- Streptomyces lavendulae NRRL IDA[114, 115]f
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These subunits may be encoded by any combination of
separate genes or domain fusions (Fig. 1a) [26], but in
the case of LanT exporters all domains are usually fused
into a single polypeptide (Fig. 1a). Class I and II lantibi-
otic exporters use different solutions to link RiPP matu-
ration to export. We illustrate these two strategies using
examples of the exporters for (pre-)nisin (class I) and
nukacin (class II). Due to the high degree of conserva-
tion of biosynthetic logic among lantibiotics [27, 31], we
do not include in Table 1 all other instances of class I
and II lantibiotic exporters, examples of which can be
found in [27].
The nisin system from Lactococcus lactis uses the ABC
transporter NisT [35, 36] (Fig. 1a). Like all RiPPs, nisin is
synthesized from the ribosome as a prepropeptide, NisA,
containing a leader sequence that directs the post-transla-
tional modification of NisA’s core and is eventually
removed. Unlike most RiPPs, however, class I lantibiotics
are secreted in an inactive form that still carries the leader
peptide, and are then activated by the extracellular protease
NisP [27, 31]. NisT is required for the secretion of pre-nisin,
and uses the leader peptide for substrate recognition
[35, 36]. In heterologous expression studies, van den Berg
van Saparoea and colleagues [36] showed that in the
Table 1. cont.
Exporter SFa TCDB BGCb Class Producer GO Evidence
Codesc
containing 2564
PurT (Pur8) MFS 2.A.1.3.11 Puromycin Aminoacyl-
nucleoside
Streptomyces alboniger IDA[116, 117]f
GouM MFS Gougerotin Peptidyl nucleoside Streptomyces graminearus IDA[71], IMP[71],
IGI[118]
ActC MFS 2.A.1.3.7 Actinorhodin BIQn Streptomyces coelicolor A3(2) IMP[66]
ActAm MFS 2.A.1.3.25 Actinorhodin BIQn Streptomyces coelicolor A3(2) IMP[63, 66]
ActBm RND 2.A.6.5.1 Actinorhodin BIQn Streptomyces coelicolorA3(2) IMP[63, 66]
Examples of proteins originally assigned as BGC-linked exporters
OtrC4-C5 ABC MDR Streptomyces rimosus IDA[48, 57]f
Ptr MFS 2.A.1.3.5 MDR Streptomyces pristinaespiralis IDA[78]f
OleB ABCF 3.A.1.120.3 Oleandomycin Macrolide Streptomyces antibioticus IDA[95]f
a, superfamily
b, we use here the final product’s name as a shorthand for each BGC. The final product, however, may not be the actual substrate of the exporter in
each case.
c, GeneOntology Evidence Codes. Based on the full definition of each GO evidence code (http://geneontology.org/docs/guide-go-evidence-codes/), we
established that we only needed to use three codes, namely IDA (inferred from direct assay), IMP (inferred frommutant phenotype), and IGI (inferred from
genetic interaction). We used the IDA evidence code whenever biochemical or cell biological assays were carried out to provide evidence for a transporter
gene’smolecular function and/or role in a biological process. We also used IDAwhenever an expression systemwas used as a way to investigate the nor-
mal function of the gene. We used the IMP evidence code in those cases when the function or biological role of a transporter gene was inferred based on
differences in behaviour between two different alleles of that gene, e.g. in comparisons between WT v. deleted/KO loci. We also used IMP when heterolo-
gous expression was used to compare alleles. Finally, we used IGI for studies where transport genes were deleted or manipulated together with other
genes in the BGC, and for functional complementation studies where a transporter gene from one organism was used to functionally replace that of the
native organism. Numbers in parenthesis behind GO evidence codes identify the literature references that we used to understand if and how each trans-
porter was implicated in BGC function.
d, plasmid-borne BGC.
e, this BGC is largely uncharacterized.
f, confers resistance upon heterologous or ectopic expression.
g, the genes for these exporters were not studied individually, but within a polycistronic fragment containing also other genes. Each protein is a
TMD+NBD fusion.
h, while the evidence suggests NysG and NysH form a heterodimer, this is not definitively demonstrated and the two transporters could function
independently.
i, NRPK: non-ribosomal peptide synthetase; PKS: polyketide synthase.
j, this envelope-spanning complex has been studied in both Pseudomonas sp. M18 and P. protegens Pf-5, but using different gene names. Fig. 1 uses
the nomenclature of [97], also adopted by TCDB.
k, based on>70% ID with LanJ.
l, based on>70% ID with Ptr.
m, in the reference provided, the actAB genes have been studied as a bicistron, not individually – see the main text.
n, benzoisochromanequinone.
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absence of NisT the amount of extracellular pre-nisin (NisP
was not included in the reconstructed system) dropped 100-
fold, and a probable nisin degradation product concomi-
tantly accumulated in the cytoplasm. The class I lantibiotic
exporter NisT then serves as a crucial player in nisin pro-
duction in L. lactis by bridging the biosynthesis of pre-nisin
in the cytoplasm with nisin’s activation on the outside.
The biosynthesis of class II lantibiotics fully integrates the
exporter into the maturation process, as exemplified by the
case of nukacin ISK-1 from Staphylococcus warneri ISK-1
[37]. In this case, the ABC exporter NukT, which now
incorporates a dedicated peptidase domain (PEP) at its N-
terminus, is directly responsible for removing the leader
peptide from the RiPP precursor, which has been shown
both in vivo and in vitro [37–39] (Fig. 1a). Leader peptide
cleavage by NukT occurs in the cytoplasm before secretion
on the fully post-translationally modified substrate, and it
is required for substrate recognition and export by NukT
[38]. Using both mutagenesis studies of NukT heterolo-
gously expressed in different hosts and elegant in vitro
assays with NukT reconstituted in proteoliposomes, the
Sonomoto group in Japan established not only that the
PEP domain plays an essential role in export, but also that
PEP and NBD domains act cooperatively stimulating each
other’s activity [38, 39].
Because of their structural and functional properties, NukT-
like ABC transporters are referred to as either AMS (ABC
transporter for maturation and secretion) [38] or PCAT
(peptidase-containing ABC transporter) [40]. The coopera-
tion between PEP and NBD domains within NukT repre-
sents a remarkable device to subordinate export to the
maturation process, and insight into how this is achieved is
offered by the crystal structure of the related PCAT1 trans-
porter from Clostridium thermocellum (Fig. 1a), which
shows extensive contacts between the PEP domain and the
transporter core, including the NBDs [40]. While the
C. thermocellum system has not been investigated in vivo so
far, the in vitro characterization of PCAT1’s interaction
with the putative substrate, the bacteriocin-like Cthe_0535
gene product, established the PEP domain as the docking
site for the substrate on the transporter, and also demon-
strated that optimal cleavage is only achieved through a
physical interaction between PEP domain and transporter
core [40]. Intriguingly, the Sonomoto group [39] has raised
the point that there might be differences in the way PEP–
NBD coupling works in different PCAT/AMS exporters:
whilst the PEP and NBD domains of PCAT1, expressed and
purified separately, still appeared to cooperate (at least to a
degree), those of NukT did not, indicating that the full-
length architecture of the protein mediates coordination in
this case [39, 40]. In this context, noteworthy are some
results in [38], where a control mutant of NukT, carrying a
single mutation in the PEP domain external to the catalytic
site, displayed increased peptidase activity in membrane
vesicles, and led to a 50% increase in the amount of mature
nukacin in vivo. It is not established whether this mutant
truly reflected some altering to PEP–NBD coordination, but
its phenotype tantalizingly suggests there might be further
layers of regulation underpinning NukT’s function.
Importantly neither of these NisT-like and NukT-like
exporters are involved in resistance to the active (extracellu-
lar) form of the lantibiotic, which instead relies on the syn-
ergistic action of a different ABC exporter, generically
termed LanFEG, and of an accessory membrane-associated
protein (LanI or LanH), all encoded within the same cluster
as lanT [27] (Fig. 1a illustrates the case of NisFEG and
NisI). While LanFEG exporters are not ubiquitous among
lantibiotic producers, and their impact to resistance may
vary [41], their mechanism of action may involve extraction
of exogenous lantibiotic embedding itself into the cell mem-
brane, followed by handover to LanI/LanH for final removal
[41]. LanT- and LanFEG-type exporters, whilst both ABC
transporters, are not closely phylogenetically related [27].
Transporters may affect product maturation in other ways.
An intriguing example is provided by the ABC transporters
NysG and NysH (Fig. 1a) involved in the biosynthetic
export of the antifungal macrolide nystatin in Streptomyces
noursei [42]. Deletion of either transporter gene caused a ca.
35% reduction in the levels of fully formed nystatin and led
to concomitant enrichment of a deoxy precursor. Plasmid-
borne copies of either gene could only complement their
cognate deletion, indicating that NysG and NysH work in
concert [42] or might even form a heterodimer (as tenta-
tively depicted in Fig. 1a). Over-expression of the hydroxy-
lase NysL could partly alleviate the phenotype of the
transporter mutants [42]. Remarkably, nystatin, either in its
mature form or as its deoxy precursor, appeared to be nor-
mally secreted regardless of nysG and nysH deletions, indi-
cating that other transport systems contribute to export in
the producer [42]. To explain these data, the authors
hypothesized that a NysGH complex might preferentially
export fully formed nystatin and that this activity would
increase the efficiency of the last biosynthetic step through
product removal [42]. In the absence of NysGH, biosyn-
thetic efficiency would be compromised, but other, less
selective transport systems would take over secretion of
both nystatin and the deoxy precursor [42]. Further investi-
gation is needed to clarify the function and specificity of
NysGH as a nystatin exporter, not to mention the interplay
with other possible transporters, but this work may be taken
to illustrate the important point that the ability to extrude
the final product might affect flux balances and have an
impact on product maturation.
Effect on self-immunity
Some transporters play a crucial role in preventing self-
intoxication of an antibiotic producer by pumping out the
final, active product before it reaches toxic levels in the cyto-
plasm. If detoxification is somehow compromised, produc-
tion may be negatively affected, and cell viability may also
drop drastically.
Severi and Thomas, Microbiology 2019;165:805–818
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The clearest example of an exporter coupled to biosynthesis
to prevent self-intoxication is provided by the McjD ABC
exporter (Fig. 1a) from the BGC of the lassopeptide Mccj25
(another RiPP), produced by certain plasmid-bearing E. coli
strains [43–45]. Disruption of mcjD was lethal to cells that
carried the rest of the plasmid-borne cluster [43, 46]. The
lethality of the mcjD deletion could be overcome by a spon-
taneous mutation in the intracellular target, with these
mutant cells accumulating mature Mccj25 in the cytoplasm
[43]. Expression of mcjD in these cells restored secretion of
Mccj25 into the external milieu [43]. Interestingly, expres-
sion of mcjD could confer resistance to exogenously added
MccJ25 in E. coli [46], which raises questions as to how the
substrate enters McjD.
McjD has been characterized at atomic and mechanistic
level by a series of elegant studies led by the Beis group in
London in collaboration with other laboratories [44, 45, 47]
(Fig. 1a). High-resolution crystal structures of McjD showed
an occluded conformation that atypically remained so in
either apo- or ADP-VO4-bound forms [44, 45]. PELDOR
measurements confirmed these data, while evidence for
transient opening was provided by Hoechst transport assays
and cross-linking experiments in the presence of Mccj25
[44]. The authors commented that this semi-permanent
occlusion of the internal, putative substrate-binding cavity
within the transporter might be at the bases of the trans-
porter specificity for MccJ25, thus constituting a key differ-
ence from MDR exporters, which tend instead to display
more open structures ‘at rest’ [44]. Very recent in vitro stud-
ies using solution NMR and ATPase assays have investi-
gated the specificity of McjD towards MccJ25, and
identified a stretch of four residues within the substrate as
the primary recognition site for export [47]. This is import-
ant knowledge that can inform rational design of substrate
variants of pharmaceutical interest that can still be exported
by McjD, and we await further studies on this very interest-
ing system.
Indirect evidence (effect on resistance in
heterologous hosts)
Roles in self-immunity have also been historically assigned
to those transporter genes that, when heterologously
expressed, could confer resistance to exogenously added
antibiotics. This strategy to identify dedicated antibiotic
exporters is a major source of ‘false positives’, which besides
the blatant case of the ABCF proteins mentioned above also
include transporter genes not linked to a BGC. For instance,
genuine MDR efflux pumps like OtrC4-C5 (Table 1; ‘OtrC’
in much of the literature) and Ptr (Table 1, Fig. 1b), have
been assigned roles in native antibiotic production, because
they could confer heterologous resistance to various mole-
cules including the target, but, with their genes not residing
within the relevant BGCs and being regulated indepen-
dently [48–50], it is not clear how, if at all, their MDR quali-
ties are attuned to BGC functions. While we can still make
important points from these examples (see below), we think
these proteins should not be ranked as true BGC-linked
antibiotic exporters until more evidence becomes available.
The use of heterologous expression must be understood as a
tool to discover and start investigating uncharacterized
exporter genes, while providing indirect evidence for a
native role in self-immunity. Unlike other types of genetic
studies, heterologous expression has the immediate positive
outcome that it starts informing us on the substrate specific-
ity of the exporters. For some of these exporters there is
accompanying direct evidence that they play a native role in
self-immunity; however, whether this holds true for the
entire group is open to investigation. We present here some
significant examples to illustrate this diverse experimental
landscape.
The daunorubicin/doxorubicin ABC exporter DrrAB from
Streptomyces peucetius (Fig. 1a) was originally assigned as a
resistance factor through heterologous expression in S. livid-
ans [51] and in E. coli [52]. It was a later work [53], how-
ever, that helped clarify the physiological role of the
transporter in the producer. After making a double drrAB
mutant, which proved more sensitive to exogenous dauno-/
doxorubicin and also produced less antibiotic, Srinivan and
colleagues [53] connected the observed phenotype to a feed-
back transcriptional regulatory mechanism, where deficient
export has a part in downregulating some of the biosyn-
thetic genes (we will see more examples of regulatory roles
below). The authors reported they could not produce a tri-
ple deletion mutant lacking drrAB and drrC [53], where
DrrC is UvrA-like additional resistance factor [54]. Since
individual drrAB and drrC deletions could be made in S.
peucetius, the authors argued for a cooperative role of
DrrAB and DrrC in self-immunity [53].
Heterologous expression studies of the ABC exporter,
CmrAB, encoded within the chromomycin A3 BGC of
S. griseus, led the authors to important insights as to the
transporter’s substrate specificity and, combined with more
evidence, to the possible physiological role in the natural
producer [55]. Compared to the entire BGC, the cmrAB
genes could only confer partial resistance to chromomycin
A3 in the heterologous host S. albus and needed the syner-
gistic action of the uvrA-like gene, cmrX for the full effect
[55]. The cmrAB genes were however sufficient for full
resistance against the closely related antibiotic mithramy-
cin, and, significantly, also against the di-deacytaled pre-
cursor of chromomycin A3, DDACA3, which has lower
yet detectable antibiotic activity [55]. Chromomycin A3 is
produced from DDACA3 by the action of the membrane-
bound acetyltransferase CmmA, and, consistently, a cmmA
deletion mutant of S. griseus could only make DDACA3
[55]. As DDACA3 was still released into the supernatant,
the authors concluded that this precursor might be the
true substrate of CmrAB [55]. A prominent role for
CmrAB in self-immunity to DDACA3 was hypothesized
following failed attempts to delete cmrAB in S. griseus,
especially when considered that adjacent genes including
cmrX could be deleted [55].
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It is worth noting that, while the specificity of CmrAB seems
to be partly relaxed, that of the equivalent ABC transporter
from the mithramycin BGC, MtrAB from S. argillaceus,
does not, as heterologous resistance was only seen to
mithramycin [56]. Mithramycin and chromomycin A3
share the same aglycone structure, but they differ by the
type of glycosylation and accompanying acetylation that
subsequently modify this core [55]. We do not know what
the molecular bases might be for this difference in substrate
specificity, and only comparative structure-function studies
on CmrAB and MtrAB can start informing this very inter-
esting question.
Heterologous expression was also used to identify oxytetra-
cycline-resistance factors from the industrially relevant
natural producer, Streptomyces rimosus [57], of which one
was the transporter, OtrB (Fig. 1b). OtrB is a member of
the superfamily of MFS transporters, which unlike ABC
transporters are energized by proton or cation gradients
and are normally encoded by a single gene (Fig. 1b). The
otrB gene has been independently isolated twice (under
different names) by transforming sensitive organisms such
as S. griseus and S. lividans, with genomic libraries from S.
rimosus and Kitasatospora (formerly Streptomyces) aureo-
faciens, which were then selected for growth on tetracy-
cline [58, 59]. otrB-expressing transformants were found to
be resistant to as high as >200 g ml 1 tetracycline [58].
Two more (oxy)tetracycline resistance factors from S.
rimosus have been isolated through heterologous expres-
sion: OtrA, an elongation factor involved in ribosome pro-
tection, and the ABC transporter mentioned above, OtrC4-
C5 (‘OtrC’), responsible for resistance to a range of antimi-
crobials including tetracycline (47, 56; see also references
therein). The interplay among these three factors in deter-
mining specific resistance to oxytetracycline, and most
importantly in actively producing cells, has not been inves-
tigated, nor has the exact physiological role of OtrB in S.
rimosus [57], although some works showed that over-
expressing otrB in the producer may lead to a modest
increase in oxytetracycline production [60, 61]. Whatever
this native role might be, we should remark that the otrB
gene has been shown to be a substrate of HGT leading to
AMR (24; see below). The case of OtrC4-C5 informs us as
to how more information is really required to assign a
BGC-linked transporter: the otrC locus was found to con-
fer only low and unspecific resistance to tetracycline in
heterologous hosts, and it is not physically linked to the
otr cluster in S. rimosus, indicating OtrC4-C5 might act as
a ‘generalist’ MDR efflux protein rather than a dedicated
oxytetracycline exporter [57]. This argues for OtrB to be
the main route of oxytetracycline export during production
[57].
Finally, another intriguing case is provided by the MFS
transporter, VarS, implicated in virginiamycin export
(Fig. 1b). Virginiamycin, produced by Streptomyces virgin-
iae, is a streptogramin comprising of two separate antibiotic
components, Virginiamycin M1 (VM1) and Virginiamycin
S (VS), which are synthesized by a ‘super cluster’ and are
most active when present as a mixture [50, 62]. VarS was
confirmed to play a role in efflux after expression of its gene
in S. lividans could confer resistance to both sole VS and a
7 : 3 mixture of VM1:VS [62]. As the intrinsic tolerance to
VM1 in S. lividans was unaltered by varS, the authors con-
cluded that VarS was specific to VS [62]. While the physio-
logical role of VarS in S. virginiae has not been established,
one should be cautious with the conclusion that VarS can-
not export VM1. If resistance to given external concentra-
tions of antibiotic is used as a proxy for export function, we
must then point out that S. lividans without varS was
already resistant to a concentration of VM1 much higher
than that used for the VM1:VS mixture, and no other con-
centrations were tested [62]. The experimental conditions
make it impossible to discern any VM1-specific effects, and
we cannot rule out that VarS might be able to export both
components. However, if we do espouse the hypothesis that
VarS is specific for VS, this raises the interesting questions
as to which export route is taken by VM1, and how the two
export processes might be coordinated to ensure that the
mixture – the most active form of the antibiotic, is delivered
when required.
It is clear from the above examples that heterologous
expression lets us into important features of antibiotic
export and is a powerful tool to isolate new exporter genes.
Our take-home message is ultimately that one should always
appraise the available evidence very carefully before drawing
conclusions as to how exporters identified in this manner
relate to the functioning of the BGCs of interest.
Effect on regulation of BGC expression
The studies on DrrAB have introduced us to the concept
that antibiotic exporters may play key roles in regulating the
expression of their home BGCs. Well-studied and highly
significant examples of this ability are ActA (ActII-ORF2)
and ActB (ActII-ORF3), respectively MFS and RND (root-
nodulation-division) exporters, involved in actinorhodin
production in Streptomyces coelicolor (Fig. 1b). ActA and
ActB are crucial players in the sophisticated feed-forward
mechanism proposed by the Nodwell group in Canada, by
which secretion of the end product by an actively producing
subpopulation within a culture leads to the transcriptional
activation of the BGC in the rest of the cells [63, 64]. The
starting observation was that cultures of the double actAB
mutant could only produce a fifth of the levels of actinorho-
din compared to WT [63, 64]. This phenotype was
explained using a set of very elegant genetic studies involv-
ing a mutant form of the ActR repressor: as first hypothe-
sized by Tahlan and colleagues [64], Xu and colleagues [63]
showed that activation of actinorhodin production occurs
in two waves where expression of key act genes, including
the actAB operon, is initially induced by a biosynthetic
intermediate; this transient transcriptional burst ultimately
results in actinorhodin production, but it grows into full
induction only once the accumulating actinorhodin is
secreted out of the cells. The results of cross-feeding
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experiments mixing an actinorhodin-producing strain with
isogenic non-producing reporter strains were consistent
with extracellular actinorhodin serving as a signal secreted
by an actively producing subpopulation to induce sustained
activation of the pathway within the entire culture [63, 64].
Despite the undeniable links between actAB gene expression
and actinorhodin production, which strongly suggest that
actinorhodin might be indeed secreted via ActA and ActB,
the authors recommended caution with identifying ActA
and ActB as bona fide actinorhodin exporters as their export
activity was not investigated directly, and some actinorho-
din was still made and secreted in the double actAB mutant
[63] (see also below). A role for ActA and ActB in prevent-
ing self-intoxication was also discussed, as a strain that
could activate actAB only transiently showed stunted
growth over longer fermentation times [63].
ActC (ActVA-ORF1) is a third exporter (MFS) that has
been implicated in actinorhodin production based on its
gene upregulation in response to pH drops, which is con-
comitant with enhanced actinorhodin secretion [65, 66].
While actC mutants have been made and phenotyped to a
degree [66], the exact role of ActC in actinorhodin secre-
tion/production and the interplay among the three potential
exporters are largely unexplored, though the interesting
possibility has been put forward by Xu and colleagues [63]
that ActC might be responsible for the residual actinorhodin
export in the double actAB mutant.
Feed-forward mechanisms may explain the regulation of
BGCs for the actinobacterial RiPPs, planosporicin and
microbisporicin [67, 68], studied by the Bibb group in Nor-
wich, though the exact roles of the multiple ABC trans-
porter genes in these clusters, which also seem to modulate
production and self-immunity [69, 70], have not been eluci-
dated. There is evidence for regulatory mechanisms, likely
in the form of feedback inhibition, in other systems, namely
the gougerotin BGC from Streptomyces graminearus
expressing the GouM MFS transporter, and the simocycli-
none BGC from S. antibioticus Tü 6040 expressing the
SimX MFS transporter [71, 72], though in the latter case the
effects on product yield were not investigated [72]. Export
might also regulate the expression of the bottromycin gene
cluster from Streptomyces sp. BC16019, as making the MFS
transporter gene, botT, constitutive increased bottromycin
production in a heterologous host [73].
Taken together, these works suggest that regulatory mecha-
nisms might represent a recurrent device to ensure that the
exporter function is fine-tuned with antibiotic production.
Exploitation of BGC-linked exporters in
biotechnology
The function of specific antibiotic exporters can be har-
nessed for biotechnological purposes [21, 22], and we dis-
cuss here two examples where the effects of transporter
manipulation have been investigated in industrial/over-pro-
ducing strains.
The genes for the AvtAB ABC transporter map to and are
co-expressed with the BGC for avermectin in Streptomyces
avermitilis [74]. Avermectin targets parasites and the natu-
ral producer does not need a self-immunity mechanism,
suggesting AvtAB might have a role in production [74]. In
the WT strain, deletion of either avtA or avtB had no effect
on avermectin production, while over-expression of avtAB
lead to increased levels of all eight avermectin congeners
with twofold increased levels for the B1a congener, the
only one that could be quantified with accuracy [74]. The
same phenotype could be reproduced in an industrial over-
producer [74]. Increased production could be shown to be
specific to avermectin in both the WT and industrial
strains by investigating the levels of olygomycin A, another
product made by S. avermitilis, which were found unal-
tered [74]. Strengthening the hypothesis that AvtAB func-
tion affected production through increased secretion, the
ratio between extracellular and intracellular avermectin in
the modified strains was found to be slightly, but signifi-
cantly increased [74].
Landomycin E production by Streptomyces globisporus was
also found to respond to over-expression of the BGC-linked
transporter gene, lndJ, coding for an MFS transporter [75]
(Fig. 1b). However, this study has important differences
compared to that of S. avermitilis/avermectin, in that the
responses of the WT strain and over-producing strain were
very different [75], and the interpretation of their respective
phenotypes is in our opinion not straightforward. While
deletion of lndJ had no effect on either production or resis-
tance in the WT [76], over-expression of lndJ in this same
strain increased resistance to exogenous landomycin E, but
also virtually abolished production [75]. However, in an
over-producing strain the same lndJ over-expression strat-
egy (ermE*p control on a multi-copy plasmid) had only a
small effect on resistance to exogenous product, while the
effect on production was the appearance of a second lando-
mycin form alongside control levels of landomycin E [75].
To try and rationalize this S. globisporus/landomycin E
study, we can only speculate that the genetic adaptations
giving the industrial strain its over-producing phenotype
might lead to a very different physiological and/or regula-
tory environment for transporter function to fit in, thus
causing a different response compared to WT.
Both studies bear the important biotechnological implica-
tion that transporter function can still be manipulated to
advantage in industrial strains, even though these have
already been evolved/engineered for increased production.
Even small increases in yields can result in considerable
improvements when fermentation is scaled up to industrial
level. There is possibly additional insight to gain from the
landomycin E study, in that this work makes a case for
investigating the effects of transporter manipulation in
improved strains regardless of what is observed in a refer-
ence WT strain.
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It is worthwhile to point out that genetic and structure-
function studies can also provide insights of biotechnologi-
cal value, even when not directly addressing strain
improvement. Think of the above examples of the hyperac-
tive NukT ‘control’ mutant that led to increased nukacin
yields in culture [38], and of the over-expressed botT gene
that led to reactivation of the bottromycin BGC in a heter-
ologous host [73]. It is reasonable to expect that, as
research unveils functional and mechanistic properties of
antibiotic exporters, this new knowledge might inform and
expand the repertoire of approaches at our disposal for
strain engineering.
Importance of BGC-linked exporters to AMR
Finally, we wish to consider the relationships that might
exist between production-linked export and AMR. It is
noteworthy that some BGC-linked exporters, such as, e.g.
OtrB from S. rimosus (see above), have been identified
because they could function as resistance factors in heterol-
ogous hosts. Even when a native role in self-immunity is not
confirmed, their ability to function ‘out of context’ makes
these proteins potential substrates of HGT, and in fact there
is now evidence that some exporter genes, including otrB,
have migrated from soil Actinobacteria to environmental
and even pathogenic Proteobacteria through a so-called
‘carry back’ mechanism [24]. Using primarily the examples
of cmx (Fig. 1b) and lmrA, encoding respectively chloram-
phenicol and lincomycin exporters, Jiang and colleagues
[24] showed how ‘carrier’ sequences of proteobacterial ori-
gin can first use conjugation to migrate into actinobacterial
antibiotic producers, acquire therein native self-immunity
factors including exporter genes through mechanisms of
genome plasticity (e.g. transposition), and finally return to
Proteobacteria through natural transformation and homolo-
gous recombination. While the evidence primarily relies on
very sophisticated phylogenetic studies, in vivo experiments
crucially showed that cmx could be transferred from the soil
actinobacterium, Corynebacterium resistens, to the Gram-
negative pathogen, Acinetobacter baylyi [24]. We can thus
add transporter genes to the list of environmental resistance
factors that originate from BGCs [25]. As another example
of genetically related yet functionally distinct groups, one
should think of the LanFEG-type and the CprABC-type
families of lantibiotic ABC exporters, the former highly spe-
cific and contributing to self-immunity in producers, and
the latter of broader specificity and involved in AMR to
RiPPs [41]. As bacterial genomes are being sequenced in
ever-larger numbers, we anticipate further phylogenetic
studies that will highlight many such cases of HGT of
exporter genes and will clarify the mechanisms of transfer.
If BGC-linked exporters can spread via HGT, are there
intrinsic features that make an exporter a likelier HGT sub-
strate than another? And what are their phylogenetic rela-
tionships with the so-called MDR ‘efflux pumps’ [19, 77]?
That evolutionary links might exist between these two
groups has been discussed by different authors over the
years [63, 75, 78]. As the most salient difference between
BGC-linked exporters and MDR efflux proteins seems to be
their substrate specificity, which can be very broad for
members of the latter group, the question becomes one of
how specificity evolves, and in which direction. In the
absence of direct evidence, we are left to speculation, but
one can imagine scenarios where a specific exporter leaves
its native BGC to evolve MDR capacity (see below), and
conversely where a BGC can recruit MDR efflux proteins
for secretion. That heterologous expression of BGCs deleted
for or naturally devoid of transporter genes still results in
the final product’s secretion [79, 80] lends credibility to the
latter scenario. It has been discussed that MDR efflux pro-
teins might even pre-date dedicated antibiotic exporters,
and that capture plus adaptation to BGCs might have ulti-
mately led to their specialization [78]. Phylogenetic studies
on catabolic clusters indicate that transporter genes may be
under selective pressure primarily for function, so that
related clusters may carry transporter genes of completely
different families that are nonetheless functionally inter-
changeable [81]. These studies concern substrate-specific
importers, but one can see how the same logic may apply to
antibiotic exporters, especially when these are MDR.
In the comparison between specific and ‘generalist’ export-
ers we can also see much scope for studies addressing the
exact mechanism of transport, whereby we may gain
insights into the molecular bases of substrate recognition
and specificity. These are important questions that other
research groups too have raised – for an example in the con-
text of McjD specificity (see above; 46]). It is also worth-
while to point out that some class II lantibiotics exporters,
such as EnkT, LahT and ProcT, have been shown or are pre-
dicted to transport multiple substrates [82–84], which
makes them relevant subjects of study in this regard.
Studying exporters from producing organisms might give us
insights into the links between MDR evolution and AMR
dissemination. The noteworthy case of the MFS exporter,
Ptr (Fig. 1b), unravelled through a number of publications,
can be used to illustrate potential avenues of investigation.
The pristinamycin super cluster from Streptomyces pristi-
naespiralis is highly syntenic to that of virginiamycin [50],
which identifies the MFS exporter gene, snbR, as the ortho-
logue of the candidate VS-exporter gene, varS (see above)
[50], coding for a 75% identical protein with a predicted
similar function in pristinamycin export. Prior to these find-
ings, this role had been assigned to ptr [50, 85], a gene iso-
lated from a genomic library for the ability to confer
pristinamycin and rifampicin resistance to heterologous
hosts [78]. While the Ptr exporter is approximately 70%
identical to either VarS or SnbR, its gene lies in a mono-cis-
tronic operon unlinked to the BGC, under independent and
un-coordinated regulation [49, 85, 86]. In our view, a more
accurate description of Ptr is as an MDR efflux pump,
which was already suggested in [78]. Remarkably, ptr falls
under the regulation of the heterologous transcriptional
repressor Pip when expressed in non-native hosts [49, 86],
which is due to conserved promoter sequences between ptr
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and pep, Pip’s native target, also coding for a highly similar
exporter [86]. In its native hosts, Pep contributes to MDR
against pristinamycin and other antibiotics, with Pip itself
responding to various exogenous molecules [86]. Others
have already commented that there may be evolutionary
connections among these closely related transporters [86];
our remark is that collectively these studies give us glimpses
as to how substrate specificity might change through gene
duplication followed by diversification, and how these resis-
tance genes can spread outwards to new hosts. Rigorous
phylogenetic studies on this family of transporters, attrac-
tive because of conserved members differing by physiologi-
cal role and genetic context, might reveal important bases
for the rise of MDR and the spread of AMR.
Conclusion
Through the above examples we gave a broad yet represen-
tative overview of bacterial antibiotic exporters from natural
producers. While exporters belong to different protein fami-
lies (Fig. 1, Table 1), the collective experimental evidence
for roles in antibiotic production is also varied in nature,
counting both genetic and biochemical studies, and it iden-
tifies different roles such as product maturation, gene
expression regulation, and self-immunity, to mention just
the most prominent ones (Table 1). If the literature is a trea-
sure trove of information on exporters as an ensemble, at
the level of individual exporters our knowledge is however
far from complete, as some of the cases we presented above
illustrate. Exporters make undoubtedly interesting subjects
of study – physiologically and mechanistically, and the
understanding of their contributions to antibiotic produc-
tion can have a significant impact on different lines of
inquiry.
Funding information
This work was supported by an EU H2020 Project Grant TOPCAPI ID:
720793.
Acknowledgments
We would like to thank Dr Liam Sharkey for useful discussions on
ABCF proteins.
Conflicts of interest
The authors declare that there are no conflicts of interest.
References
1. Carlet J, Pulcini C, Piddock LJ. Antibiotic resistance: a geopoliti-
cal issue. Clin Microbiol Infect 2014;20:949–953.
2. Wells V, Piddock LJV. Addressing antimicrobial resistance in
the UK and Europe. Lancet Infect Dis 2017;17:1230–1231.
3. Cox JAG, Worthington T. The ’antibiotic apocalypse’ - scaremon-
gering or scientific reporting? Trends Microbiol 2017;25:167–
169.
4. Blin K, Wolf T, Chevrette MG, Lu X, Schwalen CJ et al. Anti-
SMASH 4.0 - improvements in chemistry prediction and gene
cluster boundary identification. Nucleic Acids Res 2017;45:W36–
W41.
5. Thaker MN, Wang W, Spanogiannopoulos P, Waglechner N,
King AM et al. Identifying producers of antibacterial compounds
by screening for antibiotic resistance. Nat Biotechnol 2013;31:
922–927.
6. Wang M, Carver JJ, Phelan VV, Sanchez LM, Garg N et al. Shar-
ing and community curation of mass spectrometry data with
global natural products social molecular networking. Nat
Biotechnol 2016;34:828–837.
7. Ziemert N, Alanjary M, Weber T. The evolution of genome min-
ing in microbes - a review. Nat Prod Rep 2016;33:988–1005.
8. Moloney MG. Natural products as a source for novel antibiotics.
Trends Pharmacol Sci 2016;37:689–701.
9. Li L, Jiang W, Lu Y. New strategies and approaches for engi-
neering biosynthetic gene clusters of microbial natural prod-
ucts. Biotechnol Adv 2017;35:936–949.
10. Rigali S, Anderssen S, Nao^me A, van Wezel GP. Cracking the
regulatory code of biosynthetic gene clusters as a strategy for
natural product discovery. Biochem Pharmacol 2018;153:24–34.
11. Okada BK, Seyedsayamdost MR. Antibiotic dialogues: induction
of silent biosynthetic gene clusters by exogenous small mole-
cules. FEMS Microbiol Rev 2017;41:19–33.
12. Bartholomae M, Buivydas A, Viel JH, Montalban-López M,
Kuipers OP. Major gene-regulatory mechanisms operating in
ribosomally synthesized and post-translationally modified pep-
tide (RiPP) biosynthesis. Mol Microbiol 2017;106:186–206.
13. Reen FJ, Romano S, Dobson AD, O’Gara F. The sound of silence:
activating silent biosynthetic gene clusters in Marine Microor-
ganisms. Mar Drugs 2015;13:4754–4783.
14. Mattern DJ, Valiante V, Unkles SE, Brakhage AA. Synthetic biol-
ogy of fungal natural products. Front Microbiol 2015;6.
15. Martín JF, Casqueiro J, Liras P. Secretion systems for second-
ary metabolites: how producer cells send out messages of
intercellular communication. Curr Opin Microbiol 2005;8:282–
293.
16. Liu L, Hao T, Xie Z, Horsman GP, Chen Y. Genome mining
unveils widespread natural product biosynthetic capacity in
human oral microbe Streptococcus mutans. Sci Rep 2016;6:1.
17. Wilkens S. Structure and mechanism of ABC transporters.
F1000Prime Rep 2015;7:1.
18. Yan N. Structural biology of the major facilitator superfamily
transporters. Annu Rev Biophys 2015;44:257–283.
19. Blanco P, Hernando-Amado S, Reales-Calderon JA, Corona F,
Lira F et al. Bacterial multidrug efflux pumps: much more than
antibiotic resistance determinants. Microorganisms 2016;4:14.
20. Nah HJ, Pyeon HR, Kang SH, Choi SS, Kim ES. Cloning and het-
erologous expression of a large-sized natural product biosyn-
thetic gene cluster in Streptomyces species. Front Microbiol
2017;8.
21. Kell DB, Swainston N, Pir P, Oliver SG. Membrane transporter
engineering in industrial biotechnology and whole cell biocataly-
sis. Trends Biotechnol 2015;33:237–246.
22. Lv H, Li J, Wu Y, Garyali S, Wang Y. Transporter and its engi-
neering for secondary metabolites. Appl Microbiol Biotechnol
2016;100:6119–6130.
23. Alcalde-Rico M, Hernando-Amado S, Blanco P, Martínez JL.
Multidrug efflux pumps at the crossroad between antibiotic
resistance and bacterial virulence. Front Microbiol 2016;7:1–
14.
24. Jiang X, Ellabaan MMH, Charusanti P, Munck C, Blin K et al. Dis-
semination of antibiotic resistance genes from antibiotic pro-
ducers to pathogens. Nat Commun 2017;8:15784–15787.
25. Laskaris P, Tolba S, Calvo-Bado L, Wellington EM, Wellington L.
Coevolution of antibiotic production and counter-resistance in
soil bacteria. Environ Microbiol 2010;12:783–796.
26. Mendez C, Salas JA. The role of ABC transporters in antibiotic-
producing organisms: drug secretion and resistance mecha-
nisms. Res Microbiol 2001;152:341–350.
27. Gebhard S. ABC transporters of antimicrobial peptides in Firmi-
cutes bacteria - phylogeny, function and regulation. Mol
Microbiol 2012;86:1295–1317.
Severi and Thomas, Microbiology 2019;165:805–818
815
28. Mak S, Xu Y, Nodwell JR. The expression of antibiotic resistance
genes in antibiotic-producing bacteria. Mol Microbiol 2014;93:
391–402.
29. Duquesne S, Destoumieux-Garzón D, Peduzzi J, Rebuffat S.
Microcins, gene-encoded antibacterial peptides from enterobac-
teria. Nat Prod Rep 2007;24:708.
30. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS et al.
Ribosomally synthesized and post-translationally modified pep-
tide natural products: overview and recommendations for a uni-
versal nomenclature. Nat Prod Rep 2013;30:108–160.
31. Repka LM, Chekan JR, Nair SK, van der Donk WA. Mechanistic
understanding of lanthipeptide biosynthetic enzymes. Chem Rev
2017;117:5457–5520.
32. Sharkey LK, Edwards TA, O’Neill AJ. ABC-F proteins mediate
antibiotic resistance through ribosomal protection. mBio 2016;7:
1–10.
33. Murina V, Kasari M, Takada H, Hinnu M, Saha CK et al. ABCF
ATPases involved in protein synthesis, ribosome assembly and
antibiotic resistance: structural and functional diversification
across the tree of life. J Mol Biol 2018.
34. Saier MH, Reddy VS, Tsu BV, Ahmed MS, Li C et al. The Trans-
porter Classification Database (TCDB): recent advances. Nucleic
Acids Res 2016;44:D372–D379.
35. Kuipers A, de Boef E, Rink R, Fekken S, Kluskens LD et al. NisT,
the transporter of the lantibiotic nisin, can transport fully modi-
fied, dehydrated and unmodified prenisin and fusions of the
leader peptide with non-lantibiotic peptides. J Biol Chem 2004;
279:22176–22182.
36. van den Berg van Saparoea HB, Bakkes PJ, Moll GN, Driessen
AJ. Distinct contributions of the nisin biosynthesis enzymes
NisB and NisC and transporter NisT to prenisin production by
Lactococcus lactis. Appl Environ Microbiol 2008;74:5541–5548.
37. Nishie M, Shioya K, Nagao J, Jikuya H, Sonomoto K. ATP-
dependent leader peptide cleavage by NukT, a bifunctional ABC
transporter, during lantibiotic biosynthesis. J Biosci Bioeng 2009;
108:460–464.
38. Nishie M, Sasaki M, Nagao J, Zendo T, Nakayama J et al. Lanti-
biotic transporter requires cooperative functioning of the pepti-
dase domain and the ATP binding domain. J Biol Chem 2011;
286:11163–11169.
39. Zheng S, Nagao JI, Nishie M, Zendo T, Sonomoto K. ATPase
activity regulation by leader peptide processing of ABC trans-
porter maturation and secretion protein, NukT, for lantibiotic
nukacin ISK-1. Appl Microbiol Biotechnol 2018;102:763–772.
40. Lin DY, Huang S, Chen J. Crystal structures of a polypeptide
processing and secretion transporter. Nature 2015;523:425–
430.
41. Clemens R, Zaschke-Kriesche J, Khosa S, Smits SHJ. Insight
into two ABC transporter families involved in lantibiotic resis-
tance. Front Mol Biosci 2017;4:1.
42. Sletta H, Borgos SE, Bruheim P, Sekurova ON, Grasdalen H
et al. Nystatin biosynthesis and transport: nysH and nysG genes
encoding a putative ABC transporter system in Streptomyces
noursei ATCC 11455 are required for efficient conversion of 10-
deoxynystatin to nystatin. Antimicrob Agents Chemother 2005;49:
4576–4583.
43. Solbiati JO, Ciaccio M, Farías RN, Jose E, Moreno F et al.
Sequence analysis of the four plasmid genes required to pro-
duce the circular peptide antibiotic microcin J25 sequence anal-
ysis of the four plasmid genes required to produce the circular
peptide antibiotic microcin J25. 1999;181:2659–2662.
44. Bountra K, Hagelueken G, Choudhury HG, Corradi V, El Omari K
et al. Structural basis for antibacterial peptide self-immunity by
the bacterial ABC transporter McjD. EMBO J 2017:e201797278.
45. Choudhury HG, Tong Z, Mathavan I, Li Y, Iwata S et al. Structure
of an antibacterial peptide ATP-binding cassette transporter in a
novel outward occluded state. Proc Natl Acad Sci USA 2014;111:
9145–9150.
46. Solbiati JO, Ciaccio M, Farías RN, Salomón RA. Genetic analysis
of plasmid determinants for microcin J25 production and immu-
nity. J Bacteriol 1996;178:3661–3663.
47. Romano M, Fusco G, Choudhury HG, Mehmood S, Robinson CV
et al. Structural basis for natural product selection and export
by bacterial ABC transporters. ACS Chem Biol 2018;13:1598–
1609.
48. Petkovic´ H, Cullum J, Hranueli D, Hunter IS, Peric´-Concha N
et al. Genetics of Streptomyces rimosus, the oxytetracycline pro-
ducer. Microbiol Mol Biol Rev 2006;70:704–728.
49. Salah-Bey K, Thompson CJ. Unusual regulatory mechanism for
a Streptomyces multidrug resistance gene, ptr, involving three
homologous protein-binding sites overlapping the promoter
region. Mol Microbiol 1995;17:1109–1119.
50. Mast Y, Weber T, Gölz M, Ort-Winklbauer R, Gondran A et al.
Characterization of the ’pristinamycin supercluster’ of Strepto-
myces pristinaespiralis. Microb Biotechnol 2011;4:192–206.
51. Guilfoile PG, Hutchinson CR. A bacterial analog of the mdr gene
of mammalian tumor cells is present in Streptomyces peucetius,
the producer of daunorubicin and doxorubicin. Proc Natl Acad
Sci USA 1991;88:8553–8557.
52. Kaur P. Expression and characterization of DrrA and DrrB pro-
teins of Streptomyces peucetius in Escherichia coli: DrrA is an
ATP binding expression and characterization of DrrA and DrrB
proteins of Streptomyces peucetius in Escherichia coli: DrrA is an
ATP bindi. 1997;179:569–575.
53. Srinivasan P, Palani SN, Prasad R. Daunorubicin efflux in Strep-
tomyces peucetius modulates biosynthesis by feedback regula-
tion. FEMS Microbiol Lett 2010;305:18–27.
54. Prija F, Prasad R. DrrC protein of Streptomyces peucetius
removes daunorubicin from intercalated dnrI promoter.
Microbiol Res 2017;202:3030–35.
55. Menendez N, Braña AF, Salas JA, Mendez C. Involvement of a
chromomycin ABC transporter system in secretion of a deacety-
lated precursor during chromomycin biosynthesis. Microbiology
2007;153:3061–3070.
56. Fernandez E, Lombó F, Mendez C, Salas JA. An ABC trans-
porter is essential for resistance to the antitumor agent mithra-
mycin in the producer Streptomyces argillaceus. Mol Gen Genet
1996;251:692–698.
57. Petkovic´ H, Lukežic T,Šuškovic´ J. Biosynthesis of oxytetracy-
cline by Streptomyces rimosus: past, present and future direc-
tions in the development of tetracycline antibiotics. Food Technol
Biotechnol 2017;55:3–13.
58. Ohnuki T, Katoh T, Imanaka T, Aiba S. Molecular cloning of
tetracycline resistance genes from Streptomyces rimosus in
Streptomyces griseus and characterization of the cloned
genes. J Bacteriol 1985;161:1010–1016.
59. Reynes JP, Calmels T, Drocourt D, Tiraby G. Cloning, expression
in Escherichia coli and nucleotide sequence of a tetracycline-
resistance gene from Streptomyces rimosus. J Gen Microbiol
1988;134:585–598.
60. Chu X, Zhen Z, Tang Z. Introduction of extra copy of oxytetracy-
cline resistance gene otrB enhances the biosynthesis of oxytet-
racycline in Streptomyces rimosus. J Bioprocess Biotech 2012;02:
3–6.
61. Yin S, Wang X, Shi M, Yuan F, Wang H et al. Improvement of
oxytetracycline production mediated via cooperation of resis-
tance genes in Streptomyces rimosus. Sci China Life Sci 2017;60:
992–999.
62. Lee CK, Kamitani Y, Nihira T, Yamada Y. Identification and in
vivo functional analysis of a virginiamycin S resistance gene
(varS) from Streptomyces virginiae. J Bacteriol 1999;181:3293–
3297.
Severi and Thomas, Microbiology 2019;165:805–818
816
63. Xu Y, Willems A, Au-Yeung C, Tahlan K, Nodwell JR. A two-step
mechanism for the activation of actinorhodin export and resis-
tance in Streptomyces coelicolor. mBio 2012;3:1–11.
64. Tahlan K, Ahn SK, Sing A, Bodnaruk TD, Willems AR et al. Initia-
tion of actinorhodin export in Streptomyces coelicolor. Mol
Microbiol 2007;63:951–961.
65. Kim YJ, Song JY, Hong SK, Smith CP, Chang YK. Effects of pH
shock on the secretion system in Streptomyces coelicolor A3(2).
J Microbiol Biotechnol 2008;18:658–662.
66. Bystrykh LV, Fernandez-Moreno MA, Herrema JK, Malpartida
F, Hopwood DA et al. Production of actinorhodin-related "blue
pigments" by Streptomyces coelicolor A3(2). J Bacteriol 1996;
178:2238–2244.
67. Sherwood EJ, Bibb MJ. The antibiotic planosporicin coordinates
its own production in the actinomycete Planomonospora alba.
Proc Natl Acad Sci USA 2013;110:E2500–E2509.
68. Foulston L, Bibb M. Feed-forward regulation of microbisporicin
biosynthesis in Microbispora corallina. J Bacteriol 2011;193:
3064–3071.
69. Sherwood EJ, Hesketh AR, Bibb MJ. Cloning and analysis of the
planosporicin lantibiotic biosynthetic gene cluster of Planomono-
spora alba. J Bacteriol 2013;195:2309–2321.
70. Foulston LC, Bibb MJ. Microbisporicin gene cluster reveals
unusual features of lantibiotic biosynthesis in actinomycetes.
Proc Natl Acad Sci USA 2010;107:13461–13466.
71. Wei J, Tian Y, Niu G, Tan H. GouR, a TetR family transcriptional
regulator, coordinates the biosynthesis and export of gougerotin
in Streptomyces graminearus. Appl Environ Microbiol 2014;80:
714–722.
72. Le Tbk FHP, den Hengst CD, Ahn SK, Maxwell A, Buttner MJ.
Coupling of the biosynthesis and export of the DNA gyrase inhib-
itor simocyclinone in Streptomyces antibioticus. Mol Microbiol
2009;72:1462–1474.
73. Huo L, Rachid S, Stadler M, Wenzel SC, Mu R. Article synthetic
biotechnology to study and engineer ribosomal bottromycin.
Biosynthesis 2012:1278–1287.
74. Qiu J, Zhuo Y, Zhu D, Zhou X, Zhang L et al. Overexpression of
the ABC transporter AvtAB increases avermectin production in
Streptomyces avermitilis. Appl Microbiol Biotechnol 2011;92:337–
345.
75. Ostash I, Ostash B, Walker S, Fedorenko V. Proton-dependent
transporter gene lndJ confers resistance to landomycin E in
Streptomyces globisporus. Genetika 2007;43:1032–1037.
76. Ostash I, Rebets Y, Ostash B, Kobylyanskyy A, Myronovskyy M
et al. An ABC transporter encoding gene lndW confers resis-
tance to landomycin E. Arch Microbiol 2008;190:105–109.
77. Delmar JA, Su CC, Yu EW. Bacterial multidrug efflux transport-
ers. Annu Rev Biophys 2014;43:93–117.
78. Blanc V, Salah-Bey K, Folcher M, Thompson CJ. Molecular
characterization and transcriptional analysis of a multidrug
resistance gene cloned from the pristinamycin-producing
organism, Streptomyces pristinaespiralis. Mol Microbiol 1995;17:
989–999.
79. Ostash B, Doud E, Walker S. ABC transporter genes from Strep-
tomyces ghanaensis moenomycin biosynthetic gene cluster:
roles in antibiotic production and export. Arch Microbiol 2012;
194:915–922.
80. Bennallack PR, Burt SR, Heder MJ, Robison RA, Griffitts JS.
Characterization of a novel plasmid-borne thiopeptide gene
cluster in Staphylococcus epidermidis strain 115. J Bacteriol
2014;196:4344–4350.
81. Thomas GH. Sialic acid acquisition in bacteria-one substrate,
many transporters. Biochem Soc Trans 2016;44:760–765.
82. Sushida H, Ishibashi N, Zendo T, Wilaipun P,
Leelawatcharamas V et al. Evaluation of leader peptides that
affect the secretory ability of a multiple bacteriocin transporter,
EnkT. J Biosci Bioeng 2018;126:23–29.
83. Ishibashi N, Himeno K, Masuda Y, Perez RH, Iwatani S et al.
Gene cluster responsible for secretion of and immunity to multi-
ple bacteriocins, the NKR-5-3 enterocins. Appl Environ Microbiol
2014;80:6647–6655.
84. Bobeica SC, Dong SH, Huo L, Mazo N, McLaughlin MI et al.
Insights into AMS/PCAT transporters from biochemical and
structural characterization of a double Glycine motif protease.
eLife 2019;8:1–27.
85. Bamas-Jacques N, Lorenzon S, Lacroix P, De Swetschin C,
Crouzet J. Cluster organization of the genes of Streptomyces
pristinaespiralis involved in pristinamycin biosynthesis and resis-
tance elucidated by pulsed-field gel electrophoresis. J Appl
Microbiol 1999;87:939–948.
86. Folcher M, Morris RP, Dale G, Salah-Bey-Hocini K, Viollier PH
et al. A transcriptional regulator of a pristinamycin resistance
gene in Streptomyces coelicolor. J Biol Chem 2001;276:1479–
1485.
87. McNicholas S, Potterton E, Wilson KS, Noble ME. Presenting
your structures: the CCP4mg molecular-graphics software. Acta
Crystallogr D Biol Crystallogr 2011;67:386–394.
88. Stein T, Heinzmann S, Solovieva I, Entian KD. Function of Lacto-
coccus lactis nisin immunity genes nisI and nisFEG after coordi-
nated expression in the surrogate host Bacillus subtilis. J Biol
Chem 2003;278:89–94.
89. Garrido MC, Herrero M, Kolter R, Moreno F. The export of the
DNA replication inhibitor Microcin B17 provides immunity for
the host cell. EMBO J 1988;7:1853–1862.
90. Metelev M, Serebryakova M, Ghilarov D, Zhao Y, Severinov K.
Structure of microcin B-like compounds produced by Pseudomo-
nas syringae and species specificity of their antibacterial action.
J Bacteriol 2013;195:4129–4137.
91. Metelev M, Osterman IA, Ghilarov D, Khabibullina NF, Yakimov
A et al. Klebsazolicin inhibits 70S ribosome by obstructing the
peptide exit tunnel. Nat Chem Biol 2017;13:1129–1136.
92. Widdick DA, Dodd HM, Barraille P, White J, Stein TH et al. Clon-
ing and engineering of the cinnamycin biosynthetic gene cluster
from Streptomyces cinnamoneus cinnamoneus DSM 40005. Proc
Natl Acad Sci USA 2003;100:4316–4321.
93. Menges R, Muth G, Wohlleben W, Stegmann E. The ABC trans-
porter Tba of Amycolatopsis balhimycina is required for efficient
export of the glycopeptide antibiotic balhimycin. Appl Microbiol
Biotechnol 2007;77:125–134.
94. Saleh O, Flinspach K, Westrich L, Kulik A, Gust B et al. Muta-
tional analysis of a phenazine biosynthetic gene cluster in Strep-
tomyces anulatus 9663. Beilstein J Org Chem 2012;8:501–513.
95. Rodríguez AM, Olano C, Vilches C, Mendez C, Salas JA. Strepto-
myces antibioticus contains at least three oleandomycin-resis-
tance determinants, one of which shows similarity with proteins
of the ABC-transporter superfamily. Mol Microbiol 1993;8:571–
582.
96. Olano C, Rodriguez AM, Mendez C, Salas JA. Topological studies
of the membrane component of the OleC ABC transporter
involved in oleandomycin resistance in Streptomyces antibioti-
cus. FEMS Microbiol Lett 1996;143:133–139.
97. Huang X, Yan A, Zhang X, Xu Y. Identification and characteriza-
tion of a putative ABC transporter PltHIJKN required for pyolu-
teorin production in Pseudomonas sp. M18. Gene 2006;376:68–
78.
98. Brodhagen M, Paulsen I, Loper JE. Reciprocal regulation of pyo-
luteorin production with membrane transporter gene expression
in Pseudomonas fluorescens Pf-5. Appl Environ Microbiol 2005;
71:6900–6909.
99. Schmutz E, Mühlenweg A, Li SM, Heide L. Resistance genes of
aminocoumarin producers: two type II topoisomerase genes
confer resistance against coumermycin A1 and clorobiocin.
Antimicrob Agents Chemother 2003;47:869–877.
100. Eustaquio AS, Gust B, Galm U, Chater KF, Heide L et al. Heterol-
ogous expression of novobiocin and clorobiocin biosynthetic
Severi and Thomas, Microbiology 2019;165:805–818
817
gene clusters heterologous expression of novobiocin and cloro-
biocin biosynthetic gene clusters. Appl Environ Microbiol 2005;
71:2452–2459.
101. Fomenko DE, Metlitskaya AZ, Peduzzi J, Goulard C, Katrukha
GS et al. Microcin C51 plasmid genes: possible source of hori-
zontal gene transfer. Antimicrob Agents Chemother 2003;47:
2868–2874.
102. Kinscherf TG, Willis DK. The biosynthetic gene cluster for the
beta-lactam antibiotic tabtoxin in Pseudomonas syringae.
J Antibiot 2005;58:817–821.
103. Ostash I, Ostash B, Luzhetskyy A, Bechthold A, Walker S et al.
Coordination of export and glycosylation of landomycins in
Streptomyces cyanogenus S136. FEMS Microbiol Lett 2008;285:
195–202.
104. Tu J, Li S, Chen J, Song Y, Fu S et al. Characterization and het-
erologous expression of the neoabyssomicin/abyssomicin bio-
synthetic gene cluster from Streptomyces koyangensis SCSIO
5802. Microb Cell Fact 2018;17:28.
105. Namwat W, Lee CK, Kinoshita H, Yamada Y, Nihira T. Identifica-
tion of the varR gene as a transcriptional regulator of virginia-
mycin S resistance in Streptomyces virginiae. J Bacteriol 2001;
183:2025–2031.
106. Abbas A, McGuire JE, Crowley D, Baysse C, Dow M et al. The
putative permease PhlE of Pseudomonas fluorescens F113 has
a role in 2,4-diacetylphloroglucinol resistance and in general
stress tolerance. Microbiology 2004;150:2443–2450.
107. Dhote V, Starosta AL, Wilson DN, Reynolds KA. The final step of
hygromycin A biosynthesis, oxidation of C-5’’-dihydrohygromycin
A, is linked to a putative proton gradient-dependent efflux.
Antimicrob Agents Chemother 2009;53:5163–5172.
108. Guilfoile PG, Hutchinson CR. Sequence and transcriptional analysis
of the Streptomyces glaucescens tcmAR tetracenomycin C resis-
tance and repressor gene loci. J Bacteriol 1992;174:3651–3658.
109. Chater KF, Bruton CJ. Resistance, regulatory and production
genes for the antibiotic methylenomycin are clustered. EMBO
J 1985;4:1893–1897.
110. Neal RJ, Chater KF. Nucleotide sequence analysis reveals simi-
larities between proteins determining methylenomycin A resis-
tance in Streptomyces and tetracycline resistance in eubacteria.
Gene 1987;58:229–241.
111. Thaker MN, García M, Koteva K, Waglechner N, Sorensen D
et al. Biosynthetic gene cluster and antimicrobial activity of the
elfamycin antibiotic factumycin. Medchemcomm 2012;3:1020–
1026.
112. Zhang HZ, Schmidt H, Piepersberg W. Molecular cloning and
characterization of two lincomycin-resistance genes, lmrA and
lmrB, from Streptomyces lincolnensis 78-11. Mol Microbiol 1992;
6:2147–2157.
113. Peschke U, Schmidt H, Zhang HZ, Piepersberg W. Molecular
characterization of the lincomycin-production gene cluster of
Streptomyces lincolnensis 78-11. Mol Microbiol 1995;16:1137–
1156.
114. Sheldon PJ, Mao Y, He M, Sherman DH. Mitomycin resistance in
Streptomyces lavendulae includes a novel drug-binding-protein-
dependent export system. J Bacteriol 1999;181:2507–2512.
115. Mao Y, Varoglu M, Sherman DH. Molecular characterization and
analysis of the biosynthetic gene cluster for the antitumor anti-
biotic mitomycin C from Streptomyces lavendulae NRRL 2564.
Chem Biol 1999;6:251–263.
116. Tercero JA, Espinosa JC, Lacalle RA, Jimenez A. The biosyn-
thetic pathway of the aminonucleoside antibiotic puromycin, as
deduced from the molecular analysis of the pur cluster of
Streptomyces alboniger. J Biol Chem 1996;271:1579–1590.
117. Tercero JA, Lacalle RA, Jimenez A. The pur8 gene from the pur
cluster of Streptomyces alboniger encodes a highly hydrophobic
polypeptide which confers resistance to puromycin. Eur J
Biochem 1993;218:963–971.
118. Du D, Zhu Y, Wei J, Tian Y, Niu G et al. Improvement of
gougerotin and nikkomycin production by engineering their
biosynthetic gene clusters. Appl Microbiol Biotechnol 2013;97:
6383–6396.
Severi and Thomas, Microbiology 2019;165:805–818
818
Five reasons to publish your next article with a Microbiology Society journal
1. The Microbiology Society is a not-for-profit organization.
2. We offer fast and rigorous peer review – average time to first decision is 4–6 weeks.
3. Our journals have a global readership with subscriptions held in research institutions around
the world.
4. 80% of our authors rate our submission process as ‘excellent’ or ‘very good’.
5. Your article will be published on an interactive journal platform with advanced metrics.
Find out more and submit your article at microbiologyresearch.org.
